Status: current, Primitive. Date: 31-Aug 2018. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2680311000168115 | Olmesart HCT 20/12.5 (GxP) (trade product) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2680321000168110 | Olmesart HCT 20/12.5 (GxP) | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Olmesart HCT 20/12.5 (GxP) | Is a | trade product | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Olmesart HCT 20/12.5 (GxP) tablet, 10, blister pack | has TP | True | Olmesart HCT 20/12.5 (GxP) | Inferred relationship | Some | |
| Olmesart HCT 20/12.5 (GxP) (hydrochlorothiazide 12.5 mg + olmesartan medoxomil 20 mg) tablet, 10 tablets (trade product pack) | has TP | True | Olmesart HCT 20/12.5 (GxP) | Inferred relationship | Some | |
| Olmesart HCT 20/12.5 (GxP) tablet | Is a | True | Olmesart HCT 20/12.5 (GxP) | Inferred relationship | Some | |
| Olmesart HCT 20/12.5 (GxP) tablet, 30, blister pack | has TP | True | Olmesart HCT 20/12.5 (GxP) | Inferred relationship | Some | |
| Olmesart HCT 20/12.5 (GxP) tablet, 30 | has TP | True | Olmesart HCT 20/12.5 (GxP) | Inferred relationship | Some |
Reference Sets
FHIR